© 2004 by BMJ Publishing Group & British Cardiac Society
Mini-symposium
Treating multivessel disease in the era of coated stents: introduction
Royal Brompton & Harefield NHS Trust, London, UK
Correspondence to:
Correspondence to:
Professor Carlo di Mario
Royal Brompton & Harefield NHS Trust, Sydney Street, London SW3 6NP, UK; r.wall@rbh.nthames.nhs.uk
| The first 150 words of the full text of this article appear below. |
Numerous reports in cardiology congresses and journals deal with multivessel treatment with percutaneous transluminal coronary angioplasty (PTCA) and stenting. Clinical practice, however, is very different with more than 90% of all percutaneous revascularisation procedures in Europe and the USA limited to single vessel treatment. Even when performed in patients with multivessel disease, PTCA is often only performed in one vessel. In unstable syndromes intervention may be limited to the treatment of the culprit lesion and the more complete surgical or percutaneous revascularisation is postponed to a different session. With the introduction of coronary stents and the use of powerful inhibitors of platelet function the technique of angioplasty has reached a mature phase. Immediate technical success can be achieved in patients with multivessel disease with a low rate of complications, with the notable exception of chronic total occlusion. The presence of diffuse distal disease is also a technical challenge that is,
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
